Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies

2016-06-26 20:34:29 | BioPortfolio

Published on BioPortfolio: 2016-06-26T20:34:29-0400

Clinical Trials [850 Associated Clinical Trials listed on BioPortfolio]

Feasibility of Single Session In-Room Yttrium-90 Radioembolization Diagnostic Angiography and Treatment

The goal of this clinical research study is to learn about the safety of giving SIR-Spheres treatment to patients with liver cancer in the same session rather than over 2 sessions, which i...

Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors

This phase I trial studies the side effects and best dose of alisertib when given together with combination chemotherapy in treating patients with gastrointestinal tumors. Alisertib may st...

Alisertib in Treating Patients With Advanced or Metastatic Sarcoma

This phase II trial studies how well alisertib works in treating patients with advanced or metastatic sarcoma. Alisertib may stop the growth of tumor cells by blocking some of the enzymes ...

Pembrolizumab and BL-8040 in Metastatic Pancreatic Cancer

The goal of this clinical research study is to learn about the effectiveness, safety, and tolerability of pembrolizumab in combination with BL-8040 when given to patients with advanced pan...

Atezolizumab and Bevacizumab in Rare Solid Tumors

The goal of this clinical research study is to learn if atezolizumab and bevacizumab can help to control rare solid tumors.

PubMed Articles [4179 Associated PubMed Articles listed on BioPortfolio]

MR Imaging of Pleural Neoplasms.

The pleura may be affected by primary tumors or metastatic spread of intrathoracic or extrathoracic neoplasms. Primary pleural neoplasms represent ∼10% of all pleural tumors, and malignant lesions a...

Incidental Gynecologic Tract Neoplasms in Women Undergoing Anterior Pelvic Exenteration for Urothelial Carcinoma.

Urothelial carcinoma (UC) invasive into the muscularis propria or tumors unresponsive to treatment are indications for cystectomy. In females, with the goal of achieving complete cancer eradication an...

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer.

In estrogen receptor-positive (ER+) breast cancer models, activation of Aurora A kinase (AURKA) is associated with downregulation of ERα expression and resistance to endocrine therapy. Alisertib is a...

Examining the Incidence and Presentation of Melanoma in the Cardiothoracic Transplant Population.

The immunosuppression vital to maintaining transplanted organs comes with an increased incidence of cutaneous neoplasms. Understanding the genesis of malignant melanoma (MM) in transplant subpopulatio...

SOX10/keratin dual-color immunohistochemistry: An effective first-line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens.

The characterization of poorly differentiated neoplasms in fine-needle aspiration (FNA) and small biopsy specimens usually requires immunohistochemistry (IHC) with a panel of markers. Because of an in...

Medical and Biotech [MESH] Definitions

Tumors or cancer of the DIGESTIVE SYSTEM.

New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Specialized organs adapted for the reception of stimuli by the NERVOUS SYSTEM.

Benign and malignant neoplasms which occur within the substance of the spinal cord (intramedullary neoplasms) or in the space between the dura and spinal cord (intradural extramedullary neoplasms). The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.

Distinctive neoplastic disorders of histiocytes. Included are malignant neoplasms of MACROPHAGES and DENDRITIC CELLS.

More From BioPortfolio on "Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies"

Quick Search


Searches Linking to this Trial